Tropomyosin isoforms define distinct microfilament populations with different drug susceptibility.
Two tropomyosin isoforms, human Tm5(NM1) and Tm3, were over-expressed in B35 rat neuro-epithelial cells to examine preferential associations between specific actin and tropomyosin isoforms and to determine the role tropomyosin isoforms play in regulating the drug susceptibility of actin filament populations. Immunofluorescence staining and Western blot analysis were used to study the organisation of specific filament populations and their response to treatment with two widely used actin-destabilising drugs, latrunculin A and cytochalasin D. In Tm5(NM1) cells, we observed large stress fibres which showed predominant co-localisation of beta-actin and low-molecular-weight gamma-tropomyosin isoforms. Tm3 cells had an abundance of cellular protrusions which contained both the beta- and gamma-actin isoforms, predominately populated by high-molecular-weight alpha- and beta-tropomyosin isoforms. The stress fibres observed in Tm5(NM1) cells were more resistant to both latrunculin A and cytochalasin D than filaments containing the high-molecular-weight tropomyosins observed in Tm3 cells. Knockdown of the over-expressed Tm5(NM1) isoform with a human-specific Tm5(NM1) siRNA reversed the phenotype and caused a reversal in the observed drug resistance. We conclude that there are preferential associations between specific actin and tropomyosin isoforms, which are cell type specific, but it is the tropomyosin composition of a filament population which determines the susceptibility to actin-targeting drugs.
Creed
Sarah J
SJ
The Children's Hospital at Westmead and Discipline of Paediatrics and Child Health, The University of Sydney, Westmead, NSW 2145, Australia. sjcreed@hotmail.com
Bryce
Nicole
N
Naumanen
Perttu
P
Weinberger
Ron
R
Lappalainen
Pekka
P
Stehn
Justine
J
Gunning
Peter
P
D008841:Actin Cytoskeleton / Q000187:drug effects* / Q000378:metabolism; D000818:Animals; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000494:pharmacology; D002478:Cells, Cultured; D015638:Cytochalasin D / Q000494:pharmacology; D003599:Cytoskeleton / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008970:Molecular Weight; D020033:Protein Isoforms / Q000032:analysis / Q000235:genetics / Q000378:metabolism; D051381:Rats; D053778:Thiazolidines / Q000494:pharmacology; D014335:Tropomyosin / Q000032:analysis / Q000235:genetics / Q000378:metabolism / Q000502:physiology*
D019086:Bridged Bicyclo Compounds, Heterocyclic; D020033:Protein Isoforms; C498783:TPM3 protein, human; D053778:Thiazolidines; D014335:Tropomyosin; D015638:Cytochalasin D; C037067:latrunculin A